OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $116,000 | -71.1% | 11,584 | -59.1% | 0.00% | -75.0% |
| Q2 2021 | $401,000 | +568.3% | 28,300 | +86.8% | 0.00% | +100.0% |
| Q4 2018 | $60,000 | -96.2% | 15,146 | -91.1% | 0.00% | -98.7% |
| Q1 2017 | $1,575,000 | -17.8% | 169,628 | -25.9% | 0.16% | -36.3% |
| Q4 2016 | $1,916,000 | +1239.9% | 228,901 | +995.1% | 0.25% | +933.3% |
| Q3 2016 | $143,000 | +47.4% | 20,903 | +6.3% | 0.02% | +9.1% |
| Q2 2016 | $97,000 | – | 19,670 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |